Who may participate

Each clinical study has its own guidelines for who may participate, called eligibility criteria. These factors can include your age, sex, overall health, type and stage of disease, and personal treatment history. However, only the research study staff can determine if you qualify to enroll in the study.

Condition
Healthy
Sex
Male or Female
Age
18 - 65 years
Healthy participants
Yes

Eligibility criteria

Study overview

This study aims to learn how the body handles tilrekimig when given with another medicine called recombinant human hyaluronidase PH20 (rHuPH20). rHuPH20 is approved to help some medicines be taken up by the body when they are given together as an injection (shot) under the skin.

View locations for this study

Find the closest location, your results will be shown below
Find the closest location
    Miles
    0500

    Nearest Locations found

    1 site found

    New Haven Pfizer Clinical Research Unit (NH PCRU)

    New Haven, Connecticut, United States, 06511
    Site Info
    • Recruitment Status
    • Site details
    • Study Contact
    • Clinical Trials ID

    Study Locations

    View locations for this studyFind the closest location, your results will be shown belowFind the closest location